Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    9273986 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus
Conditions: Cytomegalovirus Infections;   Inflammatory Bowel Diseases
Intervention: Drug: Valganciclovir

Study has passed its completion date and status has not been verified in more than two years.